e-learning
resources
London 2016
Monday, 05.09.2016
Assessing lower airway inflammation with different tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Early and late effect of acute bronchodilation on exhaled nitric oxide in asthma
Lucas Demey (Bruxelles, Belgium), Lucas Demey, Alain Van Muylem, Alain Michils
Source:
International Congress 2016 – Assessing lower airway inflammation with different tools
Session:
Assessing lower airway inflammation with different tools
Session type:
Poster Discussion
Number:
1837
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lucas Demey (Bruxelles, Belgium), Lucas Demey, Alain Van Muylem, Alain Michils. Early and late effect of acute bronchodilation on exhaled nitric oxide in asthma. Eur Respir J 2016; 48: Suppl. 60, 1837
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Ambulatory monitoring of exhaled nitric oxide in childhood asthma exacerbation
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Exhaled nitric oxide (eNO): an early indicator of asthma relapse in children
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005
Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Exhaled nitric oxide as a predictor of exacerbations of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008
Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity
Source: Eur Respir J 2015; 45: 98-106
Year: 2015
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Different patterns of exhaled NO response to acute bronchodilation in asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Exhaled nitric oxide and clinical phenotype of childhood asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019
Year: 2019
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007
The effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in the breath condensate of adults with mild asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002
Exhaled nitric oxide is more a biomarker of atopy than asthma
Source: Annual Congress 2009 - Inflammation and airways
Year: 2009
Effect of caffeine on exhaled nitric oxide measurements in asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003
Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 677s
Year: 2006
The role of exhaled nitric oxide in the evaluation of chronic cough
Source: Eur Respir J 2006; 28: Suppl. 50, 794s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept